Home » Impax Confirms Patent Challenge Relating to Oracea
Impax Confirms Patent Challenge Relating to Oracea
Impax Laboratories, Inc. confirms that it has initiated a challenge of the patents listed by Galderma Laboratories, L.P. in connection with its Oracea (doxycycline) delayed-release capsules, 40 mg.
Forbes
Forbes
Upcoming Events
-
07May
-
14May
-
30May